Valerian

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Valerian is a plant used in some non-prescription natural health products.

Generic Name
Valerian
DrugBank Accession Number
DB13196
Background

Valerian is extracted from a herb that is a perennial flowering plant. Valerian root is reported to have sedative and anxiolytic effects however its mechanism of action is not completely understood. Valerian has been used in the treatment of conditions including sleep disorders, anxiety, attention deficit-hyperactivity disorder (ADHD) and joint pain. Valproic acid is a derivative of valeric acid, which is obtained from the plant root. Valerian is a food ingredient permitted for direct addition to food for human consumption as a natural flavoring substance.

Type
Biotech
Groups
Approved, Experimental, Investigational
Biologic Classification
Allergenics
Allergen Extract
Synonyms
  • Valerianae radix

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Artryl Cap 200 mgCapsule200 mgOralLes Laboratoires Vachon Inc.1994-12-312007-07-12Canada flag
Effidose Valeriane Liq 1916mg/10ml AmpLiquid1.916 g / ampOralLaboratoires Charton Laboratories1995-12-311999-01-16Canada flag
Ethical Herbals Sleep AidTablet170 mgOralAshbury Research CorporationNot applicableNot applicableCanada flag
Facilite Le Sommeil - Cap 270mgCapsule270 mgOralLaboratoire Lalco Inc.1997-01-202002-09-05Canada flag
Hermes No6 TeaLiquid120 mg / 5 mLOralHermes Arzneimittel Gmbh1958-12-311999-07-08Canada flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Bio-strath No. 8 GouttesValerian (0.225 mL / mL) + Passiflora incarnata flower (0.225 mL / mL) + Peppermint (0.05 mL / mL)Solution / dropsOralBio Strath Ag1989-12-312008-07-24Canada flag
Dormiphen Au NaturelValerian (400 mg) + Passiflora incarnata flower (400 mg)CapsuleOralLaboratoire Lalco Inc.Not applicableNot applicableCanada flag
GLICERO VALEROVITValerian (20 mg/ml) + Sodium glycerophosphate (10 mg/ml)SyrupOralTeofarma S.R.L.2014-07-08Not applicableItaly flag
GLICERO VALEROVITValerian (20 mg/2ml) + Sodium glycerophosphate (100 mg/2ml)Injection, solutionIntramuscularTeofarma S.R.L.2014-07-08Not applicableItaly flag
GLICERO VALEROVITValerian (20 mg/mL) + Sodium glycerophosphate (10 mg/mL)SyrupOralTeofarma S.R.L.2014-07-082022-02-16Italy flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Medi-doze Rx Sleep AidValerian (50 mg/1) + Melatonin (6 mg/1) + gamma-Aminobutyric acid (30 mg/1)TabletOralTwo Hip Consulting, Llc2013-02-202016-04-11US flag

Categories

ATC Codes
N05CM09 — Valerianae radix
Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
JWF5YAW3QW
CAS number
8057-49-6

References

General References
Not Available
PubChem Substance
347911444
RxNav
253206
Wikipedia
Valerian

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3Unknown StatusTreatmentAnxiety Disorders1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
CapsuleOral
CapsuleOral200 mg
Solution / dropsOral
LiquidOral1.916 g / amp
TabletOral170 mg
CapsuleOral270 mg
Injection, solutionIntramuscular
SyrupOral
LiquidOral120 mg / 5 mL
CapsuleOral175 mg
TabletOral
TabletOral500 mg / tab
CapsuleOral
CapsuleOral170 mg / cap
TabletOral600 mg / tab
PatchCutaneous0.8 g/8g
CapsuleOral150 mg / cap
TabletOral600 mg
TabletOral140 mg / tab
TinctureOral166.7 mg / mL
PowderOral
CapsuleOral100 mg / tab
TabletOral100 mg
CapsuleOral560 mg
For solutionOral
TinctureOral200 mg / mL
CapsuleOral300 mg
CapsuleOral410 mg / cap
CapsuleOral500 mg / cap
CapsuleOral500 mg
CapsuleOral450 mg / cap
TabletOral800 mg / tab
CapsuleOral400 mg
CapsuleOral470 mg
CapsuleOral470 mg / cap
TinctureOral435 mg / mL
LiquidOral.125 g / mL
Tablet, coated
Tablet, coatedOral
TabletOral140 mg
CapsuleOral270 mg / cap
LiquidOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at June 23, 2017 20:37 / Updated at March 18, 2024 16:48